MTS Assay Protocol: Cell Proliferation and Viability Measurement

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-07-15

Key Takeaways

• The MTS assay quantifies cell metabolic activity, serving as a surrogate for viable cell number by measuring the bioreduction of MTS tetrazolium salt to a soluble formazan product via NAD(P)H-dependent oxidoreductase enzymes.
• The assay's principle relies on the direct proportionality between formazan production and the number of metabolically active cells, detected spectrophotometrically at 490-500 nm.
• Key controls are essential for accurate interpretation, including a no-cell blank to account for reagent and medium absorbance, a vehicle control to assess solvent effects, and a positive control (e.g., Triton X-100) to establish maximum cytotoxicity.
• Advantages over the MTT assay include the direct production of a water-soluble formazan, eliminating the need for a solubilization step, thereby simplifying the protocol and reducing potential variability.
• Potential limitations include interference from reducing compounds present in test agents or media, high serum concentrations, and the presence of phenol red, which can all lead to false-positive signals or elevated background absorbance.
• The assay is sensitive to changes in cellular metabolism, meaning that compounds affecting metabolic pathways without directly impacting viability can yield misleading results, necessitating confirmation with independent viability assays like LDH or colony formation assays.

The MTS assay is a colorimetric method for measuring cell metabolic activity as a surrogate for cell proliferation and viability. It relies on the bioreduction of a tetrazolium compound, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium), into a soluble, colored formazan product by NAD(P)H-dependent oxidoreductase enzymes in metabolically active cells. This assay is useful for comparing relative cell numbers across treatment groups, screening cytotoxic compounds, and monitoring cell growth over time in adherent or suspension cell cultures. Unlike the MTT assay, MTS produces a water-soluble formazan that does not require a solubilization step, simplifying the protocol and reducing variability.

At a Glance

Scientific Principle

The MTS assay is based on the reduction of a tetrazolium salt by metabolically active cells. Viable cells contain NAD(P)H-dependent oxidoreductase enzymes that transfer electrons from NADH or NADPH to the tetrazolium compound, cleaving the tetrazolium ring and forming a colored formazan product. The amount of formazan produced is directly proportional to the number of viable cells, provided that the metabolic activity per cell remains constant across experimental conditions.

MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) is a second-generation tetrazolium salt that, unlike MTT, produces a formazan product that is soluble in aqueous culture medium. This eliminates the need for a solubilization step with DMSO or acidified isopropanol, reducing handling steps and potential errors. The MTS reagent is typically supplied as a ready-to-use solution or as a powder that is reconstituted with an electron coupling reagent (e.g., phenazine methosulfate, PMS) to enhance reduction efficiency.

The assay endpoint is measured by absorbance spectrophotometry at 490-500 nm. The formazan product has a broad absorption peak, and the exact wavelength depends on the specific reagent formulation. Most commercial MTS reagents recommend reading at 490 nm with a reference wavelength of 650-690 nm to correct for background absorbance from cell debris and the culture medium.

Materials and Instrumentation

Reagents

• MTS reagent: Available from multiple commercial suppliers (e.g., CellTiter 96® AQueous One Solution, Promega; MTS Assay Kit, Abcam). Store protected from light at -20°C or 4°C according to manufacturer instructions. Avoid repeated freeze-thaw cycles.
• Culture medium: Complete growth medium appropriate for the cell type. Serum concentration can affect background absorbance; use the same medium for all wells.
• Positive control: 0.1-1% Triton X-100 in culture medium to induce complete cell lysis.
• Vehicle control: Culture medium containing the same concentration of solvent (e.g., DMSO, ethanol) as the treatment groups.
• Phosphate-buffered saline (PBS): For washing cells if needed.

Equipment

• Microplate reader: Capable of measuring absorbance at 490 nm (or 490-500 nm) with a reference wavelength of 650-690 nm. Monochromator or filter-based readers are acceptable.
• CO₂ incubator: Maintained at 37°C with 5% CO₂ and humidified atmosphere.
• Laminar flow hood: BSL-1 certified for routine cell culture work.
• Multichannel pipette: For efficient reagent addition to 96-well plates.
• Reagent reservoirs: Sterile, for multichannel pipetting.
• Microcentrifuge: For pelleting suspension cells if needed.
• Hemocytometer or automated cell counter: For initial cell counting and seeding.

Plate Selection

Use tissue culture-treated, flat-bottom 96-well plates for adherent cells. For suspension cells, use low-attachment plates or round-bottom plates to prevent cell aggregation. Clear plates are required for absorbance-based detection; black or white plates are not suitable unless the assay is modified for fluorescence detection.

Controls and Experimental Design

Essential Controls

• No-cell blank: Culture medium with MTS reagent but without cells. This measures background absorbance from the medium and reagent.
• Vehicle control: Cells treated with the same concentration of solvent (e.g., DMSO, ethanol) as the experimental groups. This controls for solvent effects on cell viability.
• Positive control (cytotoxicity): Cells treated with a known cytotoxic agent (e.g., 0.1% Triton X-100) to establish the minimum absorbance signal.
• Time zero control: Measure absorbance immediately after MTS addition to establish baseline values for kinetic studies.

Replicates and Plate Layout

Use at least three technical replicates (wells) per condition. Include multiple biological replicates (independent experiments) to account for cell passage variability. Design the plate layout to minimize edge effects: avoid using the outermost wells for experimental conditions, or fill them with PBS or medium to reduce evaporation.

Cell Seeding Density

Optimize cell seeding density for each cell type. Typical densities range from 5,000 to 20,000 cells per well for a 96-well plate, depending on cell size and growth rate. The goal is to achieve a linear relationship between cell number and absorbance within the expected experimental range. Perform a cell titration curve (e.g., 0, 1,000, 2,500, 5,000, 10,000, 20,000, 40,000 cells per well) to determine the optimal seeding density.

Conceptual Workflow

Step 1: Cell Preparation and Seeding

1. Harvest cells at 70-80% confluence using trypsin or other dissociation reagent.
2. Count viable cells using trypan blue exclusion and a hemocytometer.
3. Prepare a cell suspension at the desired concentration in complete culture medium.
4. Seed cells into a 96-well plate at 100 µL per well. For suspension cells, seed at the same volume.
5. Incubate overnight (16-24 hours) at 37°C, 5% CO₂ to allow cell attachment and recovery.

Step 2: Treatment Application

1. Remove culture medium from adherent cells by gentle aspiration. For suspension cells, centrifuge the plate at 300 × g for 5 minutes and carefully remove supernatant.
2. Add 100 µL of treatment medium (or control medium) to each well.
3. Incubate for the desired treatment duration (e.g., 24, 48, or 72 hours).

Step 3: MTS Reagent Addition

1. Thaw MTS reagent at room temperature or 37°C, protected from light. Do not heat above 37°C.
2. Add 20 µL of MTS reagent to each well containing 100 µL of culture medium (1:5 dilution). For different volumes, maintain the same ratio.
3. Gently tap the plate to mix, or use a plate shaker for 10 seconds at low speed.
4. Incubate at 37°C, 5% CO₂, protected from light, for 1-4 hours.

Step 4: Absorbance Measurement

1. Remove plate from incubator and check for color development. The medium should turn from yellow to brown-orange in wells with viable cells.
2. Measure absorbance at 490 nm with a reference wavelength of 650-690 nm using a microplate reader.
3. Record the absorbance values for each well.

Step 5: Data Analysis

1. Subtract the average absorbance of the no-cell blank from all sample and control readings.
2. Calculate the mean and standard deviation for each condition.
3. Express results as percentage of vehicle control: (Absorbance of treated sample / Absorbance of vehicle control) × 100%.
4. For proliferation studies, normalize to time zero readings to calculate fold change over time.

Quality Checks

Linearity Verification

Before running experimental samples, verify that the assay is linear over the expected cell number range. Prepare a serial dilution of cells (e.g., 0, 2,500, 5,000, 10,000, 20,000, 40,000 cells per well) and perform the MTS assay. Plot absorbance versus cell number and confirm an R² value > 0.95 for the linear regression.

Time Course Optimization

Determine the optimal incubation time for your cell type by measuring absorbance at 30-minute intervals over 4 hours. The ideal incubation time is within the linear phase of formazan production, before substrate depletion or product inhibition occurs. Most cell types require 1-3 hours, but primary cells or slow-growing cells may need longer.

Background Assessment

Measure the absorbance of the no-cell blank at the same time points. A high background (> 0.2 absorbance units) may indicate reagent degradation, contamination, or interference from the culture medium. Replace reagents if background is elevated.

Result Interpretation

Normalization Methods

• Percentage of control: Most common for cytotoxicity studies. Values below 70% of vehicle control are often considered cytotoxic, though this threshold depends on the assay and cell type.
• Fold change: Used for proliferation studies. Compare absorbance at the endpoint to the time zero reading.
• Absolute cell number: If a standard curve is generated, convert absorbance values to cell numbers using the linear regression equation.

Data Presentation

Present results as bar graphs or line graphs with error bars representing standard deviation or standard error of the mean. Include individual data points when possible to show variability. For dose-response experiments, fit a sigmoidal curve to calculate IC₅₀ values.

Common Pitfalls

• Saturation: Absorbance values above 2.0-2.5 may indicate over-reduction or too many cells. Reduce cell number or incubation time.
• Low signal: Absorbance below 0.2 after blank subtraction may indicate too few cells, short incubation, or cytotoxic treatment. Increase cell number or incubation time.
• High variability: Uneven cell seeding, edge effects, or pipetting errors can increase variability. Use multichannel pipettes and pre-wet tips.

Troubleshooting

Limitations

Interference from Reducing Agents

Compounds that directly reduce MTS (e.g., ascorbic acid, dithiothreitol, β-mercaptoethanol) will produce false-positive signals. Include a cell-free control with the test compound to detect direct reduction. If interference is observed, wash cells with PBS before adding MTS reagent.

Serum and Phenol Red Effects

High serum concentrations (>10%) can increase background absorbance. Phenol red in culture medium absorbs at 490 nm and may contribute to background. Use phenol red-free medium or include appropriate blanks. Some commercial MTS reagents are formulated to minimize these effects.

Metabolic Activity Variability

The MTS assay measures metabolic activity, not direct cell number. Treatments that alter cellular metabolism without affecting viability (e.g., growth factors, hormones, mitochondrial inhibitors) can produce misleading results. Confirm findings with an independent viability assay such as the LDH assay or colony formation assay.

Cell Type Specificity

Different cell types have different metabolic rates and may require different incubation times. Primary cells, stem cells, and slow-growing cells may need longer incubation (up to 4 hours) compared to rapidly dividing cell lines (1-2 hours). Always optimize for each cell type.

Endpoint Nature

The MTS assay provides a single time point measurement. For kinetic studies, prepare replicate plates for each time point rather than repeatedly measuring the same plate, as the formazan product may accumulate and affect subsequent readings.

Documentation

Essential Records

• Cell line information: Source, passage number, mycoplasma testing status
• Seeding density: Cells per well, volume, and method of counting
• Treatment details: Compound name, concentration, solvent, exposure time
• MTS reagent: Supplier, catalog number, lot number, expiration date
• Incubation conditions: Time, temperature, CO₂ level, light protection
• Plate layout: Well assignments for all conditions and controls
• Raw data: Absorbance readings for all wells before and after blank subtraction
• Analysis parameters: Wavelength, reference wavelength, normalization method

Data Management

Store raw plate reader data in a spreadsheet or laboratory information management system (LIMS). Document any data exclusion criteria (e.g., wells with visible bubbles, edge wells with evaporation). Archive plate layout files and analysis scripts for reproducibility.

Biosafety Considerations

The MTS assay is performed with routine cell culture procedures and falls under BSL-1 containment for most established cell lines. Follow standard microbiological practices as outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition [<a href="#ref-1">1</a>]. Key practices include:

• Work in a certified Class II biological safety cabinet for all cell culture steps.
• Decontaminate all liquid waste with 10% bleach (final concentration) before disposal.
• Use appropriate personal protective equipment (lab coat, gloves, eye protection).
• Label all plates and tubes clearly with cell line, date, and hazard information.
• For cells containing recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [<a href="#ref-2">2</a>].

The MTS reagent itself is not classified as hazardous at the concentrations used, but avoid skin contact and dispose of according to institutional hazardous waste guidelines. Formazan products are not considered toxic at assay concentrations.

Frequently Asked Questions

1. Can I use the MTS assay with suspension cells?

Yes, but modifications are needed. Seed suspension cells in low-attachment plates to prevent clumping. After treatment, centrifuge the plate at 300 × g for 5 minutes before adding MTS reagent. Gently resuspend cells after reagent addition and incubate with occasional gentle shaking to ensure even exposure.

2. How do I choose between MTS and MTT assays?

MTS is preferred when you want to avoid the solubilization step required for MTT, as MTS formazan is water-soluble. MTS is also better for kinetic studies and multiplexing with other assays. MTT may be more cost-effective for large-scale screens and is less sensitive to interference from reducing agents. Both assays measure metabolic activity and should give comparable results when optimized.

3. What is the maximum incubation time for the MTS assay?

Incubation times longer than 4 hours are not recommended because the reaction may become nonlinear due to substrate depletion, product inhibition, or cell death from prolonged exposure to the reagent. If longer incubation is needed, reduce the cell number or use a lower concentration of MTS reagent. Some commercial kits allow overnight incubation with reduced reagent volume.

4. How do I correct for interference from colored test compounds?

First, measure the absorbance of the test compound alone at 490 nm in culture medium without cells. If the compound absorbs at this wavelength, include a compound-only control (no cells) for each concentration. Subtract this background from the corresponding cell-containing wells. Alternatively, wash cells with PBS before adding MTS reagent to remove the compound.

Related Clinical & Scientific Guides

• Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of African Swine Fever Virus in Oral Fluids
• How to Calculate the Concentration of Protein Using the Lowry Assay
• DNA Extraction from Saliva: Non-Invasive Sampling and Protocols

References and Further Reading

Related Articles

• LDH Assay: Protocol for Measuring Cytotoxicity and Cell Viability
• Colony Formation Assay Protocol: Measuring Cell Reproductive Viability
• Transwell Migration Assay Protocol: Measuring Cell Migration and Invasion
• Lowry Assay Protocol: Protein Quantification Method
• Kinase Activity Assay: Methods for Measuring Protein Kinase Activity
• Immunofluorescence Assay: Principles and Protocol for Protein Localization